Search results for " Hereditary Hemorrhagic"

showing 3 items of 3 documents

Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study.

2014

Abstract Introduction Epistaxis is the most frequent manifestation in hereditary hemorrhagic telangiectasia, in which no optimal treatment exists. It can lead to severe anemia and reduced quality of life. Positive effects of tranexamic acid, an antifibrinolytic drug, have been reported on epistaxis related to this disorder. We sought to evaluate the efficacy of treating nosebleeds in hereditary hemorrhagic telangiectasia with tranexamic acid. Materials and Methods In a randomized, double-blind, placebo controlled, cross-over phase IIIB study, 1 gram of tranexamic acid or placebo was given orally 3 times daily for 3 months for a total of 6 months. Results 22 patients were included in the int…

AdultMaleAntifibrinolyticTime Factorsmedicine.drug_classMedizinAdministration OralPlaceboDrug Administration ScheduleDouble blindQuality of lifeDouble-Blind MethodGermanymedicineHumansTelangiectasiaAgedDiminutionCross-Over Studiesbusiness.industryHematologyMiddle AgedAntifibrinolytic AgentsClinical trialEpistaxisTreatment OutcomeTranexamic AcidAnesthesiaFemaleTelangiectasia Hereditary Hemorrhagicmedicine.symptombusinessTranexamic acidmedicine.drugThrombosis research
researchProduct

Health‐Related Quality of Life in Hereditary Hemorrhagic Telangiectasia

2007

Objective To assess and differentiate the health-related quality of life (HR-QoL) in patients with hereditary hemorrhagic telangiectasia (HHT). Study Design and Setting A prospective, open, cross-sectional questionnaire-based study (including the Short Form-36 Health Survey [SF-36]) performed by a tertiary care center. Results A total of 77 patients (36 females) were included. Except for one domain (bodily pain), the scores for all scales of the SF-36 were significantly reduced in comparison with normative data. The duration of epistaxis, the presence of hepatic involvement and gastrointestinal bleeding, and the number of visible telangiectases correlated with lower scores on several scales…

MaleGastrointestinal bleedingmedicine.medical_specialtyPediatricsCross-sectional studyHealth StatusMEDLINETelangiectases03 medical and health sciences0302 clinical medicineQuality of lifeRecurrenceSurveys and QuestionnairesmedicineHumansProspective Studies030223 otorhinolaryngologyProspective cohort studyTelangiectasiaHealth related quality of lifebusiness.industrymedicine.diseaseCross-Sectional StudiesOtorhinolaryngology030220 oncology & carcinogenesisQuality of LifePhysical therapyFemaleTelangiectasia Hereditary HemorrhagicSurgerymedicine.symptombusinessOtolaryngology–Head and Neck Surgery
researchProduct

Pulmonary microvascular architecture in hereditary haemorrhagic telangiectasia

2017

A 24-year-old Caucasian man was admitted with a known hereditary haemorrhagic telangiectasia (HHT) and heterozygous mutation of factor V Leiden following episodes of cerebral infarctions in occipital lobes, cerebellum and brainstem. In his case history, the patient underwent several interventional embolisation of arteriovenous (AV) malformations in the middle and lower lobes (figure 1). However, those were not completely successful as the malformations were diffuse. We performed video-assisted thoracoscopic surgery with a resection of the middle lobe and a wedge resection of segment 10. Figure 1 CT scans depict the pulmonary arteriovenous malformations after re-embolisation in the middle lo…

Pulmonary and Respiratory MedicineMalecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyMucocutaneous zoneMedizinArticleResection03 medical and health sciencesYoung Adult0302 clinical medicineMicroscopy Electron Transmissionhemic and lymphatic diseasesotorhinolaryngologic diseasesmedicineFactor V LeidenHumans030223 otorhinolaryngologyLungHeterozygous mutationHereditary haemorrhagic telangiectasiabusiness.industryMiddle LobeMicrovascular architecturemedicine.diseaseSurgery030228 respiratory systemMicrovesselsTelangiectasia Hereditary HemorrhagicRadiologybusinessTomography X-Ray ComputedWedge resection (lung)
researchProduct